Search
New York, NY (July 1, 2022) – The following is a statement from Kevin Longino, Chief Executive Officer of the National Kidney Foundation and a kidney transplant recipient, on the House Appropriations Committee’s FY 2023 Labor, Health and Human Services, Education, and Related Agencies appropriations bill.
“The National Kidney Foundation applauds the House Appropriations committee for its dedication to fighting kidney...
June 6, 2022, New York – A new study published today in the National Kidney Foundation’s (NKF) American Journal of Kidney Diseases (AJKD) warns that ultra-processed foods (UPF) and drinks are linked with increased risk of chronic kidney disease (CKD).
“Association Between Ultra-Processed Food Consumption and Risk...
Statement from the National Kidney Foundation on Media Reports of USPSTF Considering Kidney Disease Screening
May 24, 2022, New York, NY —The National Kidney Foundation (NKF) is encouraged by reports the United States Preventative Services...
~ Collaboration aims to revolutionize kidney transplantation outcomes by liberating patients from immunosuppressive medications. ~
(New York, NY, January 30, 2024) – The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical...
Potentially game changing impact investment program aimed at fundamentally disrupting the fight against kidney disease
April 11, 2022, New York, NY —The National Kidney Foundation (NKF) today, announced the launch of the NKF Innovation Fund, a new impact investment program aimed at fundamentally disrupting the fight against kidney disease.
“The kidney health landscape is...
March 31, 2022, New York, NY — Researchers will present at the National Kidney Foundation’s Spring Clinical Meetings the results of a clinical trial of a new therapy that gives hope to people with a specific genetic mutation that can cause kidney damage.
APOL1-mediated kidney disease (AMKD) is a serious disease caused by mutations in the APOL1 gene that lead to damage in certain...
February 7, 2022, New York, NY — Today, the latest guideline for managing diabetes in patients with kidney disease has been endorsed by the National Kidney Foundation’s (NKF) professional workgroup charged with reviewing the “KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.”
Led by co-chairs Drs. Amy Mottl and...
January 26, 2022, New York, NY —The National Kidney Foundation (NKF) is proud to announce that Imperial Headwear will join us once again as the “Official Headwear” and National Promotional Partner of the 35th Annual NKF Konica Minolta Golf Classic. Funds raised through this fun event help NKF promote optimal kidney health as well as improve the lives of the...
November 2, 2021, San Francisco, CA— For more than three decades, hundreds of avid readers in the San Francisco Bay Area have had the opportunity to lunch with their favorite authors during the Annual NKF Authors Luncheon Benefit. Due to the ongoing pandemic, this year’s “You’ve Read Them, Now Meet Them” event will once again be held virtually, ...
Both Organizations Recommend Race-Free Approach to Estimate GFR
Sept. 23, 2021, New York, NY – Today, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has released its final report, which outlines a new race-free...